• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿潴留——持续输注甲氧氯普胺后出现的一种罕见的肌张力障碍反应。

Urinary retention--an unusual dystonic reaction to continuous metoclopramide infusion.

作者信息

Kohli-Kumar M, Pearson A D, Sharkey I, Craft A W

机构信息

Children's Hospital Medical Center, Cincinnati, OH.

出版信息

DICP. 1991 May;25(5):469-70. doi: 10.1177/106002809102500505.

DOI:10.1177/106002809102500505
PMID:2068829
Abstract

Vomiting is one of the most distressing adverse effects of cancer chemotherapy. Metoclopramide by continuous infusion (400 micrograms/kg/h after a loading dose of 2.5 mg/kg) is a novel administration method for optimizing efficacy. A two-year-old boy developed urinary retention on three occasions, once accompanied by priapism and slurred speech, while receiving a continuous infusion. This was reversed by procyclidine, suggesting that it may have been a dystonic reaction.

摘要

呕吐是癌症化疗最令人痛苦的副作用之一。甲氧氯普胺持续输注(负荷剂量2.5mg/kg后以400微克/千克/小时的速度输注)是一种优化疗效的新给药方法。一名两岁男孩在接受持续输注时三次出现尿潴留,一次伴有阴茎异常勃起和言语不清。普环啶可逆转这种情况,提示这可能是一种张力障碍反应。

相似文献

1
Urinary retention--an unusual dystonic reaction to continuous metoclopramide infusion.尿潴留——持续输注甲氧氯普胺后出现的一种罕见的肌张力障碍反应。
DICP. 1991 May;25(5):469-70. doi: 10.1177/106002809102500505.
2
Dystonic reactions and the pharmacokinetics of metoclopramide in children.儿童的肌张力障碍反应与甲氧氯普胺的药代动力学
Br J Clin Pharmacol. 1983 May;15(5):557-9. doi: 10.1111/j.1365-2125.1983.tb02090.x.
3
Metoclopramide induced acute dystonic reaction: a case report.甲氧氯普胺诱发的急性肌张力障碍反应:一例报告
BMC Res Notes. 2017 Jan 7;10(1):32. doi: 10.1186/s13104-016-2342-6.
4
Continuous infusion of high-dose metoclopramide for the prevention of nausea and vomiting in patients receiving cancer chemotherapy.
Eur J Clin Pharmacol. 1983;25(1):35-9. doi: 10.1007/BF00544011.
5
Acute Dystonic Reactions in Children Treated for Headache With Prochlorperazine or Metoclopramide.儿童头痛治疗中使用丙氯拉嗪或甲氧氯普胺致急性肌张力障碍反应。
Pediatr Neurol. 2020 May;106:63-64. doi: 10.1016/j.pediatrneurol.2020.01.013. Epub 2020 Feb 4.
6
Familial metoclopramide-induced dystonic reactions.家族性胃复安诱发的张力障碍反应。
Mov Disord. 1992 Oct;7(4):385-6. doi: 10.1002/mds.870070420.
7
Metoclopramide--acute dystonic reactions.甲氧氯普胺——急性肌张力障碍反应。
Aust Nurses J. 1990 Aug;20(1):28-9.
8
Supraglottic dystonic reaction to metoclopramide in a child.一名儿童对甲氧氯普胺的声门上肌张力障碍反应。
Med J Aust. 2001 Jun 4;174(11):607-8. doi: 10.5694/j.1326-5377.2001.tb143454.x.
9
[Dystonic-dyskinetic syndrome following metoclopramide (Cerucal) administration to promote lactation].[使用胃复安(灭吐灵)促进泌乳后出现的张力障碍-运动障碍综合征]
Z Arztl Fortbild (Jena). 1989;83(10):539-40.
10
Pharmacokinetics and efficacy of high-dose metoclopramide given by continuous infusion for the control of cytotoxic drug-induced vomiting.持续输注高剂量胃复安控制细胞毒性药物所致呕吐的药代动力学及疗效
Br J Clin Pharmacol. 1984 Nov;18(5):679-84. doi: 10.1111/j.1365-2125.1984.tb02529.x.

引用本文的文献

1
The Safety of Metoclopramide in Children: A Systematic Review and Meta-Analysis.甲氧氯普胺在儿童中的安全性:一项系统评价和荟萃分析。
Drug Saf. 2016 Jul;39(7):675-87. doi: 10.1007/s40264-016-0418-9.
2
High incidence of acute urinary retention associated with immediate catheter removal after laparoscopic Nissen fundoplication.腹腔镜 Nissen 胃底折叠术后即刻拔除尿管与急性尿潴留的高发生率相关。
Surg Endosc. 2011 May;25(5):1611-6. doi: 10.1007/s00464-010-1460-9. Epub 2010 Dec 8.
3
Drug-induced urinary retention: incidence, management and prevention.
药物性尿潴留:发病率、管理与预防
Drug Saf. 2008;31(5):373-88. doi: 10.2165/00002018-200831050-00002.
4
Spontaneous versus precipitated AUR: the same?自发性与诱发性急性尿潴留:相同吗?
World J Urol. 2006 Sep;24(4):354-9. doi: 10.1007/s00345-006-0089-8.
5
Drug-induced bladder and urinary disorders. Incidence, prevention and management.药物性膀胱和泌尿系统疾病。发病率、预防与管理。
Drug Saf. 1998 Jul;19(1):45-55. doi: 10.2165/00002018-199819010-00004.